Cargando…
A Vasopressin-Induced Change in Prostaglandin Receptor Subtype Expression Explains the Differential Effect of PGE(2) on AQP2 Expression
Arginine vasopressin (AVP) stimulates the concentration of renal urine by increasing the principal cell expression of aquaporin-2 (AQP2) water channels. Prostaglandin E(2) (PGE(2)) and prostaglandin(2α) (PGF(2α)) increase the water absorption of the principal cell without AVP, but PGE(2) decreases i...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814457/ https://www.ncbi.nlm.nih.gov/pubmed/35126177 http://dx.doi.org/10.3389/fphys.2021.787598 |
_version_ | 1784645062803587072 |
---|---|
author | Deen, Peter M. T. Boone, Michelle Schweer, Horst Olesen, Emma T. B. Carmone, Claudia Wetzels, Jack F. M. Fenton, Robert A. Kortenoeven, Marleen L. A. |
author_facet | Deen, Peter M. T. Boone, Michelle Schweer, Horst Olesen, Emma T. B. Carmone, Claudia Wetzels, Jack F. M. Fenton, Robert A. Kortenoeven, Marleen L. A. |
author_sort | Deen, Peter M. T. |
collection | PubMed |
description | Arginine vasopressin (AVP) stimulates the concentration of renal urine by increasing the principal cell expression of aquaporin-2 (AQP2) water channels. Prostaglandin E(2) (PGE(2)) and prostaglandin(2α) (PGF(2α)) increase the water absorption of the principal cell without AVP, but PGE(2) decreases it in the presence of AVP. The underlying mechanism of this paradoxical response was investigated here. Mouse cortical collecting duct (mkpCCD(c14)) cells mimic principal cells as they endogenously express AQP2 in response to AVP. PGE(2) increased AQP2 abundance without desmopressin (dDAVP), while in the presence of dDAVP, PGE(2), and PGF(2α) reduced AQP2 abundance. dDAVP increased the cellular PGD(2) and PGE(2) release and decreased the PGF(2α) release. MpkCCD cells expressed mRNAs for the receptors of PGE(2) (EP1/EP4), PGF(2) (FP), and TxB(2) (TP). Incubation with dDAVP increased the expression of EP1 and FP but decreased the expression of EP4. In the absence of dDAVP, incubation of mpkCCD cells with an EP4, but not EP1/3, agonist increased AQP2 abundance, and the PGE(2)-induced increase in AQP2 was blocked with an EP4 antagonist. Moreover, in the presence of dDAVP, an EP1/3, but not EP4, agonist decreased the AQP2 abundance, and the addition of EP1 antagonists prevented the PGE(2)-mediated downregulation of AQP2. Our study shows that in mpkCCD(c14) cells, reduced EP4 receptor and increased EP1/FP receptor expression by dDAVP explains the differential effects of PGE(2) and PGF(2α) on AQP2 abundance with or without dDAVP. As the V2R and EP4 receptor, but not the EP1 and FP receptor, can couple to Gs and stimulate the cyclic adenosine monophosphate (cAMP) pathway, our data support a view that cells can desensitize themselves for receptors activating the same pathway and sensitize themselves for receptors of alternative pathways. |
format | Online Article Text |
id | pubmed-8814457 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88144572022-02-05 A Vasopressin-Induced Change in Prostaglandin Receptor Subtype Expression Explains the Differential Effect of PGE(2) on AQP2 Expression Deen, Peter M. T. Boone, Michelle Schweer, Horst Olesen, Emma T. B. Carmone, Claudia Wetzels, Jack F. M. Fenton, Robert A. Kortenoeven, Marleen L. A. Front Physiol Physiology Arginine vasopressin (AVP) stimulates the concentration of renal urine by increasing the principal cell expression of aquaporin-2 (AQP2) water channels. Prostaglandin E(2) (PGE(2)) and prostaglandin(2α) (PGF(2α)) increase the water absorption of the principal cell without AVP, but PGE(2) decreases it in the presence of AVP. The underlying mechanism of this paradoxical response was investigated here. Mouse cortical collecting duct (mkpCCD(c14)) cells mimic principal cells as they endogenously express AQP2 in response to AVP. PGE(2) increased AQP2 abundance without desmopressin (dDAVP), while in the presence of dDAVP, PGE(2), and PGF(2α) reduced AQP2 abundance. dDAVP increased the cellular PGD(2) and PGE(2) release and decreased the PGF(2α) release. MpkCCD cells expressed mRNAs for the receptors of PGE(2) (EP1/EP4), PGF(2) (FP), and TxB(2) (TP). Incubation with dDAVP increased the expression of EP1 and FP but decreased the expression of EP4. In the absence of dDAVP, incubation of mpkCCD cells with an EP4, but not EP1/3, agonist increased AQP2 abundance, and the PGE(2)-induced increase in AQP2 was blocked with an EP4 antagonist. Moreover, in the presence of dDAVP, an EP1/3, but not EP4, agonist decreased the AQP2 abundance, and the addition of EP1 antagonists prevented the PGE(2)-mediated downregulation of AQP2. Our study shows that in mpkCCD(c14) cells, reduced EP4 receptor and increased EP1/FP receptor expression by dDAVP explains the differential effects of PGE(2) and PGF(2α) on AQP2 abundance with or without dDAVP. As the V2R and EP4 receptor, but not the EP1 and FP receptor, can couple to Gs and stimulate the cyclic adenosine monophosphate (cAMP) pathway, our data support a view that cells can desensitize themselves for receptors activating the same pathway and sensitize themselves for receptors of alternative pathways. Frontiers Media S.A. 2022-01-21 /pmc/articles/PMC8814457/ /pubmed/35126177 http://dx.doi.org/10.3389/fphys.2021.787598 Text en Copyright © 2022 Deen, Boone, Schweer, Olesen, Carmone, Wetzels, Fenton and Kortenoeven. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Physiology Deen, Peter M. T. Boone, Michelle Schweer, Horst Olesen, Emma T. B. Carmone, Claudia Wetzels, Jack F. M. Fenton, Robert A. Kortenoeven, Marleen L. A. A Vasopressin-Induced Change in Prostaglandin Receptor Subtype Expression Explains the Differential Effect of PGE(2) on AQP2 Expression |
title | A Vasopressin-Induced Change in Prostaglandin Receptor Subtype Expression Explains the Differential Effect of PGE(2) on AQP2 Expression |
title_full | A Vasopressin-Induced Change in Prostaglandin Receptor Subtype Expression Explains the Differential Effect of PGE(2) on AQP2 Expression |
title_fullStr | A Vasopressin-Induced Change in Prostaglandin Receptor Subtype Expression Explains the Differential Effect of PGE(2) on AQP2 Expression |
title_full_unstemmed | A Vasopressin-Induced Change in Prostaglandin Receptor Subtype Expression Explains the Differential Effect of PGE(2) on AQP2 Expression |
title_short | A Vasopressin-Induced Change in Prostaglandin Receptor Subtype Expression Explains the Differential Effect of PGE(2) on AQP2 Expression |
title_sort | vasopressin-induced change in prostaglandin receptor subtype expression explains the differential effect of pge(2) on aqp2 expression |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814457/ https://www.ncbi.nlm.nih.gov/pubmed/35126177 http://dx.doi.org/10.3389/fphys.2021.787598 |
work_keys_str_mv | AT deenpetermt avasopressininducedchangeinprostaglandinreceptorsubtypeexpressionexplainsthedifferentialeffectofpge2onaqp2expression AT boonemichelle avasopressininducedchangeinprostaglandinreceptorsubtypeexpressionexplainsthedifferentialeffectofpge2onaqp2expression AT schweerhorst avasopressininducedchangeinprostaglandinreceptorsubtypeexpressionexplainsthedifferentialeffectofpge2onaqp2expression AT olesenemmatb avasopressininducedchangeinprostaglandinreceptorsubtypeexpressionexplainsthedifferentialeffectofpge2onaqp2expression AT carmoneclaudia avasopressininducedchangeinprostaglandinreceptorsubtypeexpressionexplainsthedifferentialeffectofpge2onaqp2expression AT wetzelsjackfm avasopressininducedchangeinprostaglandinreceptorsubtypeexpressionexplainsthedifferentialeffectofpge2onaqp2expression AT fentonroberta avasopressininducedchangeinprostaglandinreceptorsubtypeexpressionexplainsthedifferentialeffectofpge2onaqp2expression AT kortenoevenmarleenla avasopressininducedchangeinprostaglandinreceptorsubtypeexpressionexplainsthedifferentialeffectofpge2onaqp2expression AT deenpetermt vasopressininducedchangeinprostaglandinreceptorsubtypeexpressionexplainsthedifferentialeffectofpge2onaqp2expression AT boonemichelle vasopressininducedchangeinprostaglandinreceptorsubtypeexpressionexplainsthedifferentialeffectofpge2onaqp2expression AT schweerhorst vasopressininducedchangeinprostaglandinreceptorsubtypeexpressionexplainsthedifferentialeffectofpge2onaqp2expression AT olesenemmatb vasopressininducedchangeinprostaglandinreceptorsubtypeexpressionexplainsthedifferentialeffectofpge2onaqp2expression AT carmoneclaudia vasopressininducedchangeinprostaglandinreceptorsubtypeexpressionexplainsthedifferentialeffectofpge2onaqp2expression AT wetzelsjackfm vasopressininducedchangeinprostaglandinreceptorsubtypeexpressionexplainsthedifferentialeffectofpge2onaqp2expression AT fentonroberta vasopressininducedchangeinprostaglandinreceptorsubtypeexpressionexplainsthedifferentialeffectofpge2onaqp2expression AT kortenoevenmarleenla vasopressininducedchangeinprostaglandinreceptorsubtypeexpressionexplainsthedifferentialeffectofpge2onaqp2expression |